Hanmi gets best IR award

Published: 2006-11-23 06:58:00

Updated: 2006-11-23 06:58:00

Hanmi Pharm was selected as this year's best IR (investor relations) drug company by the Korea Economic Daily (KED), a local economic daily, for the second consecutive year.

The national leading pharmaceutical firm received the top award in the enterprise's transparency and future value catego...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK